[Chemotherapy in hormone refractory prostatic carcinoma]

Dtsch Med Wochenschr. 1999 Jul 16;124(28-29):874-9. doi: 10.1055/s-2007-1024434.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / adverse effects
  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Resistance, Neoplasm
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Antineoplastic Agents